Abstract
This is the first comparison of two combination therapies, fluticasone propionate/salmeterol and ipratropium bromide/albuterol (salbutamol), for the treatment of patients with COPD. A randomized, double-blind, double-dummy, parallel group, multicenter evaluation of fluticasone propionate/salmeterol 250/50 microg twice daily via DISKUS and ipratropium bromide/albuterol 36/206 microg four times daily via metered-dose inhaler over 8 weeks was conducted at 41 research sites in the US. Morning pre-dose FEV(1), 6-hour serial spirometry, PEF, dyspnea, night-time awakenings, supplemental albuterol use, and patient diary evaluations of symptoms were evaluated. A total of 365 patients with symptomatic COPD were enrolled. The treatment groups were similar in mean age (63.3 and 63.9 years), screening pulmonary function (44.1% and 43.2% of predicted FEV(1)), race (96% and 95% White), and sex distribution (59% and 60% male). Both fluticasone propionate/salmeterol and ipratropium bromide/albuterol improved lung function, symptoms, and supplemental albuterol use compared with baseline. Fluticasone propionate/salmeterol was more effective than ipratropium bromide/albuterol for improvement in morning pre-dose FEV(1), morning PEF, 6-hour FEV(1) a...Continue Reading
References
Mar 1, 1989·Clinical Science·R C Wilson, P W Jones
Jun 1, 1984·Chest·D A MahlerA R Feinstein
Feb 1, 1997·American Journal of Respiratory and Critical Care Medicine·J N BaraniukT Troost
Apr 20, 1999·Chest·D A MahlerW H Anderson
Jun 15, 2000·The European Respiratory Journal·J A van NoordA M Bommer
Jun 29, 2000·American Journal of Respiratory Cell and Molecular Biology·L Pang, A J Knox
Apr 24, 2001·American Journal of Respiratory and Critical Care Medicine·S I RennardK Rickard
Jun 16, 2001·Chest·R L ZuWallackK Knobil
Aug 14, 2001·American Journal of Respiratory and Critical Care Medicine·D B CoultasE Lydick
Mar 2, 2002·The European Respiratory Journal·W VinckenUNKNOWN Dutch/Belgian Tiotropium Study Group
Jul 13, 2002·Chest·James F DonohueLesley Towse
Oct 16, 2002·American Journal of Respiratory and Critical Care Medicine·Donald A MahlerTushar Shah
Nov 5, 2002·The European Respiratory Journal·S RennardJ Vestbo
Feb 7, 2003·The European Respiratory Journal·W SzafranskiH Olsson
Feb 14, 2003·Lancet·Peter CalverleyUNKNOWN TRial of Inhaled STeroids ANd long-acting beta2 agonists study group
Mar 1, 2003·The European Respiratory Journal·T J Witek, D A Mahler
May 3, 2003·Journal of Clinical Epidemiology·Theodore J Witek, Donald A Mahler
May 3, 2003·Thorax·V BrusascoS Kesten
Sep 13, 2003·Chest·Nicola A HananiaTushar Shah
Dec 19, 2003·The European Respiratory Journal·P M CalverleyH Olsson
Citations
Jan 28, 2006·American Journal of Respiratory and Critical Care Medicine·David M ManninoKourtney J Davis
Dec 1, 2007·International Journal of Chronic Obstructive Pulmonary Disease·K F Chung
Nov 30, 2007·International Journal of Chronic Obstructive Pulmonary Disease·Paolo Montuschi
Feb 12, 2011·International Journal of Chronic Obstructive Pulmonary Disease·James F Donohue, Paul W Jones
Sep 12, 2014·International Journal of Chronic Obstructive Pulmonary Disease·David PriceKatsiaryna Bichel
Feb 19, 2010·Expert Opinion on Drug Metabolism & Toxicology·Joshiah Gordon, Ralph J Panos
Feb 24, 2009·Current Medical Research and Opinion·E Rand SutherlandKimberly Denis-Mize
Feb 13, 2009·Current Medical Research and Opinion·Thomas E DeleaChristopher M Blanchette
Dec 2, 2006·COPD·James F Donohue
Sep 9, 2008·The American Journal of Geriatric Pharmacotherapy·Christopher M BlanchetteLinda Simoni-Wastila
Jun 11, 2008·Pulmonary Pharmacology & Therapeutics·Eugene R BleeckerChristopher Kalberg
Sep 26, 2006·The American Journal of Medicine·Andrew L Ries
Feb 5, 2015·International Journal of Clinical Practice·F Pozo-RodríguezUNKNOWN AUDIPOC Study Group
Dec 14, 2006·Expert Opinion on Pharmacotherapy·Laura MeinkeGanesh Krishna
Dec 21, 2006·Respiratory Medicine·Tom FardonBrian J Lipworth
Oct 22, 2005·Respiratory Medicine·Nicola A HananiaBarry Make
Jul 11, 2008·Respiratory Medicine·Gary T FergusonChristopher Kalberg
Oct 21, 2005·Respiratory Medicine·Mark T DransfieldWilliam C Bailey
Dec 9, 2009·Health and Quality of Life Outcomes·Robin F PokrzywinskiDennis A Revicki
Jun 8, 2006·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·C P Onno van Schayck, Jim Reid
Nov 12, 2013·The Cochrane Database of Systematic Reviews·Luis Javier NanniniRebecca Normansell
Sep 15, 2005·Drugs & Aging·Jordana K SchmierMechelle L Jones
Apr 1, 2005·Nonlinearity in Biology, Toxicology, Medicine·Min An
Feb 23, 2020·NPJ Primary Care Respiratory Medicine·Ioanna Tsiligianni, Janwillem W H Kocks
Oct 30, 2009·COPD·Antonio AnzuetoGlenn Crater